Search
A new targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukemia
Patients with chronic lymphocytic leukemia (CLL) that has recurred or isn’t responding to standard treatment need new therapies. A new combination of two targeted therapies is showing potential to eliminate CLL in these circumstances.
Read moreRed Cells and Iron
This SWG covers the clinical areas of inherited and acquired disorders of the erythrocyte and iron metabolism.
Read moreEHA-EMBL/EBI Computational Biology Training in Hematology
The CBTH 2025 call for applications is now closed.
Read moreEHA-SfPM Precision Medicine Meeting
EHA and SfPM (Society for Functional Precision Medicine) are proud to present the first joint meeting on Precision Medicine.
Read moreEuropean Research Initiative on CLL (ERIC)
ERIC is devoted to improving the outcome of patients with Chronic Lymphocytic Leukemia (CLL) and related diseases. The objectives of ERIC are to promote:
Research in all aspects of chronic lymphocytic leukemia and related diseases.
Aging and Hematology
The SWG "Aging and Hematology" has four main goals for the next four years (2019-2023):
To share clinically useful tools in assessing frailty and comorbidities in older adults with hematologic malignancies.
Transfusion
The aim of this SWG is to strengthen and invigorate European research in transfusion, to foster new networks and collaborations, with the ultimate goal of optomisingtransfusion practice in Europe based on scientific evidence.
Read morePriority Points System
The Priority Points System is designed to recognize sponsors’ investment and continuous support for EHA activities, and are allocated for each sponsorship program and/or item.
Read more